|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Nov 29, 2022 |
Title |
RNAseq of CD4 T cells treated with survivivin inhibitor YM155 for 24h |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
CD4 T cells from 4 healthy women were activated with aCD3 and treated with the survivin inhibitor YM155, 10 ng/ml or control during 24 hours. The last 2 hours with upplement of IFNg. The objective was to understand the action of survivin (coded by BIRC5 gene) in CD4 T cells.
|
|
|
Overall design |
4 healthy women, paired analysis possible. CD4 cells from human PBMC isolated by positive selection on Dynabeads (cat.11331D), stimulated with anti-CD3 (OKT3, Sigma-Aldrich) treated for 24h with YM155, 0 or 10nM, (Selleck Chemicals, Houston, TX) last 2 hours with addition of IFNg (50ng/ml, Peprotech, Cranbury, NJ, USA)
|
|
|
Contributor(s) |
Bokarewa MI, Andersson KM, Erlandsson MC, Oparina N |
Citation(s) |
36425763 |
|
Submission date |
Dec 07, 2021 |
Last update date |
Nov 29, 2022 |
Contact name |
Maria I Bokarewa |
E-mail(s) |
[email protected]
|
Organization name |
Gothenburg University
|
Department |
Rheumatology and Inflammation Research
|
Lab |
Bokarewa
|
Street address |
Guldhedagatan 10A
|
City |
Gothenburg |
State/province |
VG |
ZIP/Postal code |
SE41346 |
Country |
Sweden |
|
|
Platforms (1) |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
Samples (8)
|
|
This SubSeries is part of SuperSeries: |
|
Relations |
BioProject |
PRJNA786830 |
SRA |
SRP349617 |
Supplementary file |
Size |
Download |
File type/resource |
GSE190352_RNAseq_HC_CD4_IFN_IFN+YM155__24h_ds5_.xlsx |
2.8 Mb |
(ftp)(http) |
XLSX |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|